insights_auto
Perché 600664 è in calo 3,76%?
Approfondiscichevron_right
600664:SHA
Harbin Pharmaceutical Group Co Ltd
6,40 CN¥
arrow_downward
-3,76%(-0,25) 1G
13 ott, 11:30:00 GMT+8 · CNY
search
Tutti i simboli
| Simbolo | Prezzo | Cambio | % di cambio |
|---|
insights_autoGenerazione degli insight principali per 600664 in corso…
Apertura
5,99 CN¥
Massimo
6,49 CN¥
Minimo
5,99 CN¥
Cap. mercato
18,61 Mld
Vol. medio
387,72 Mln
Volume
400,97 Mln
Rapporto P/E
31,47
Max 52 sett.
9,86 CN¥
Min 52 sett.
2,84 CN¥
Utili per azione
0,20 CN¥
Azioni in circolazione
2,54 Mld
N. di dipendenti
10K
Apertura
5,99 CN¥
Massimo
6,49 CN¥
Minimo
5,99 CN¥
Cap. mercato
18,61 Mld
Vol. medio
387,72 Mln
Volume
400,97 Mln
Rapporto P/E
31,47
Max 52 sett.
9,86 CN¥
Min 52 sett.
2,84 CN¥
Utili per azione
0,20 CN¥
Azioni in circolazione
2,54 Mld
N. di dipendenti
10K
Articoli giornalistici
Da fonti web e partner giornalistici
Profilo
Harbin Pharmaceutical Group Co., Ltd. is a Chinese partially state-owned company engaged in the research & development, manufacture, and sale of pharmaceutical products. HPGC medication offerings include traditional Chinese medicine and biopharmaceuticals; its main offerings include antibiotics, including amoxicillin and penicillin, and dietary supplements, including zinc gluconate and calcium gluconate.
The company owns both Renmintongtai, a drugstore chain and medical wholesaler for the domestic market, and GNC, a U.S.-based international retailer of supplements and wellness products. Wikipedia
Informazioni su Harbin Pharmaceutical Group Co Ltd